Page 262 - Critical Care Notes
P. 262

4223_Tab10_249-258  29/08/14  10:03 AM  Page 256



                 CC MEDS
           Postoperative opioid-induced respiratory depression: IV 0.1–0.2 mg every
           2–3 min prn. Opioid overdose: IV/SC/IM 0.4 mg (10 mcg/kg) (not opioid
           dependent), may repeat every 2–3 min (opioid dependent).
          nesiritide, Natrecor: Vasodilator. Uses: Acutely decompensated CHF. Dosages:
           IV bolus 2 mcg/kg, then IV infusion 0.01 mcg/kg/min nitroglycerine: Coronary
           vasodilator, antianginal. Uses: Chronic stable angina pectoris prophylaxis of
           angina pain, CHF associated with AMI, controlled hypotension in surgical
           procedures. Dosages: SL, transdermal, topical doses available. IV infusion
           uses listed only IV 5 mcg/min, then increase by 5 mcg/min every 3–5 min; if
           no response after 20 mcg/min, increase by 10–20 mcg/min until desired
           response
          nicardipine, Cardene: Antianginal agent; calcium channel blocker, dihydropyri-
           dine. Uses: Chronic stable angina (immediate release product only); manage-
           ment of HTN (immediate and sustained release products); IV only for short-
           term use only when oral treatment not feasible. Dosing: Angina: Immediate
           release, PO 20 mg 3 times day; usual range 60–120 mg/day; increase dose at
           3-day intervals. HTN: PO immediate release initial dose 20 mg 3 times a day;
           usual dose 20–40 mg 3 times a day (allow 3 days between dose increases).
           Sustained release: Initial 30 mg twice a day. Acute HTN: IV initial dose 5 mg/hr
           increased by 2.5 mg/hr every 5 min (for rapid titration) to every 15 min (for
           gradual titration) up to max of 15 mg/hr; rapidly titrated patients, consider
           reduction to 3 mg/hr after response is achieved.
          nitroglycerin: Antianginal agent, vasodilator. Uses: Labeled indications:
           Treatment or prevention of angina pectoris. Unlabeled indications: Short-
           term management of pulmonary HTN, esophageal spastic disorders,
           uterine relaxation. Dosages: Angina/coronary artery disease: PO 2.5–6.5 mg
           3–4 times/daily. IV 5 mcg/min, increase by 5 mcg/min every 3–5 min to
           20 mcg/min. If no response at 20 mcg/min, may increase by 10–20 mcg/min
           every 3–5 min. Topical ointment 1/2 inch–2 inches every 6 hr; patch,
           transdermal 0.2–0.4 mg/hr initially and titrate to doses of 0.4–0.8 mg/hr
           (tolerance is minimized by using patch 12–14 hr/day and off 10–12 hr/day
           SL 0.3–0.6 mg every 5 min for max of 3 doses in 15 min, may also use
           prophylactically 5–10 min before activities that may provoke an attack.
           Translingual 1–2 sprays onto or under tongue every 3–5 min for max of
           3 doses in 15 min, may also be used prophylactically 5–10 min before activi-
           ties that may provoke an angina attack. Esophageal spastic disorders: SL
           0.3–0.5 mg. Uterine relaxation: IV bolus 100–200 mcg; may repeat dose
           every 2 min as necessary.
          nitroprusside, Nitropress: Antihypertensive, vasodilator. Uses: Hypertensive
           crisis, to decrease bleeding by creating hypotension during surgery, acute
           heart failure. Dosages: IV infusion dissolve 50 mg in 2–3 mL of D5W, then
           dilute in 250–1,000 mL of D5W; infuse at 0.5–8 mcg/min.
          norepinephrine, Levophed: Adrenergic. Uses: Acute hypotension, shock.
           Dosages: IV infusion 8–12 mcg/min titrated to BP.
                                256
   257   258   259   260   261   262   263   264   265   266   267